Welcome to the
Hepatitis B Foundation
Tekmira Pharma Presents TKM-HBV Preclinical Study Data
Oct 20 – Tekmira Pharmaceuticals presented preclinical results showing potent and rapid reduction of hepatitis B surface antigen (HBsAg) demonstrated using TKM-HBV, their therapeutic agent targeting hepatitis B. Read more.
Liver Transplanted Second time in Hong Kong Man
Oct 20 - Hong Kong surgeons have performed a double world first with a transplant from one Hepatitis B sufferer to another with a liver that had already been transplanted once 11 years ago. Read more.
Obesity May Speed Aging of the Liver, Study Suggests
Oct 20 – Extra pounds cause the liver to age faster, potentially explaining why obesity is linked to diseases like liver cancer and insulin resistance, new research suggests. Read more.
DOYLESTOWN, PA, October, 2014 – The Hepatitis B Foundation’s (HBF) High School Science Enrichment Program recently received an $8,500 donation from the Fulton Bank, N.A. This contribution was provided though the State’s “Educational Improvement Tax Credit” (EITC) program. The Pennsylvania EITC tax credit program allows businesses to receive tax credits for corporate state tax dollars they donate to educational programs such as the HBF’s Science Enrichment Program. Read more...
Campaign Focuses on Reducing HBV in Chinese City
Aug 25 – The Hepatitis B Foundation published initial results from its 3-year outreach campaign in Haimen City, China, which is the first of its kind to provide hepatitis B education to an entire city that included clinicians, civic leaders and the city’s 1 million residents. Read the HBF publication.
Page last modified October 7, 2014